Chronic Kidney Disease (CKD), which affects approximately 844 million people worldwide 1, typically progresses silently for years before it is diagnosed. But by then, in many cases, irreversible ...

Maze applied to be listed on the Nasdaq under the ticker symbol "MAZE," according to ... Maze plans to pursue the drug in chronic kidney disease and phenylketonuria, according to the filing.